Formulation And Evaluation Of Itraconazole Loaded Solid Lipid Nanoparticles For Tinea Cruris:A Promising Approach To Combat Antifungal Drug Resistance
Abstract
Keywords
Full Text:
PDFReferences
Boogaerts M, Maertens J. Clinical experience with itraconazole in systemic fungal infections. Drugs. 2001;61 Suppl 1:39-47.
Piérard GE, Arrese JE, Piérard-Franchimont C. Itraconazole. Expert Opin Pharmacother. 2000 Jan;1(2):287-304.
Dhiman N., Awasthi R., Sharma B., Kharkwal H., Kulkarni G.T. Lipid nanoparticles as carriers for bioactive delivery. Front Chem. 2021;9 . https://doi.org/10.3389/fchem.2021.580118
Clinard VB, Smith JD. Cutaneous Fungal Infections. US Pharm. 2015;40(4):35-9.
Sheehan DJ, Hitchcock CA, Sibley CM. Current and Emerging Azole Antifungal Agents. Clin Microbiol Rev. 1999;12(1):40-79.
Pires CA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014;89(2):259-64.
Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008;166(5-6):335
How C.W., Rasedee A., Manickam S., Rosli R. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity. Colloids Surf. B Biointerfaces. 2013;112:393–399.
Jacob S., Nair A.B., Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater. Res. 2020;24(1):1–16.
Kamboj S., Bala S., Nair A.B. Solid lipid nanoparticles: an effective lipid based technology for poorly water soluble drugs. Int. J. Pharm. Sci. Rev. Res. 2010;5(2):78–90.
DOI: https://doi.org/10.37591/rrjodfdp.v10i3.1377
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research & Reviews: A Journal of Drug Formulation, Development and Production